Product explainer video for Access Bio — rapid diagnostic test platform for 100+ countries.
Access Bio is a New Providence, New Jersey-based global health diagnostics company — a trusted partner in global health whose CareStart™, CareSuperb™, CareGene™, and CareSURE™ product platforms serve healthcare providers, governments, NGOs, and institutional buyers across more than 100 countries with the rapid diagnostic testing, molecular diagnostics, and point-of-care analyzer solutions that make accurate, timely disease detection accessible in the clinical environments where it matters most. Access Bio's product portfolio spans malaria, HIV, syphilis, dengue, G6PD deficiency, influenza, COVID-19, HPV, and the full range of infectious disease and chronic condition diagnostics that global health organizations depend on — built for both the high-resource clinical settings of North America and Europe and the resource-limited environments of sub-Saharan Africa, South and Southeast Asia, and Latin America where reliable point-of-care diagnostics are a genuine public health infrastructure need.
The CareStart™ Rapid Diagnostic Test platform is the flagship of Access Bio's diagnostic product ecosystem — a WHO-prequalified, globally distributed portfolio of rapid tests whose clinical sensitivity and specificity meet the evidence standards that institutional buyers, public health ministries, and NGO procurement teams require before committing to the large-scale deployment decisions that define global health diagnostics procurement. The CareStart™ Malaria RDT is one of the most widely distributed malaria rapid tests in the world. The CareStart™ COVID-19 Antigen and combination COVID-19/Flu detection products served the urgent global diagnostic need that the pandemic generated and remain part of the portfolio's ongoing infectious disease detection infrastructure. The CareStart™ Flu A&B Plus, G6PD, dengue, HIV, and syphilis tests extend the platform's clinical reach across the full range of infectious disease and chronic condition diagnostics that Access Bio's global distribution network delivers to clinical settings on every inhabited continent.
The product explainer video produced by VID for Access Bio was built to communicate the specific clinical value, application workflow, and ease of use that Access Bio's diagnostic products deliver to the healthcare provider, institutional buyer, and distribution partner audience evaluating point-of-care testing solutions. The clinical and institutional buyer who encounters Access Bio's products in a procurement evaluation — the hospital purchasing manager, the public health ministry official, the NGO medical supply director, or the clinical staff member whose daily diagnostic workflow the product will enter — makes adoption decisions through a combination of regulatory validation data, clinical performance evidence, and practical workflow understanding. The product explainer video addresses the practical dimension of that evaluation directly — communicating how the product works, why its design and performance make it the right solution for the specific clinical contexts it serves, and what using it in a real diagnostic setting looks and feels like.
The half-day on-site production methodology gave VID's team the direct access to Access Bio's products, environment, and team that a clinical diagnostic explainer requires — the product close-up footage, the use-case demonstration, and the organizational authenticity that makes the finished video feel grounded in the specific reality of Access Bio's clinical applications rather than the generic product marketing aesthetic that sophisticated healthcare buyers have learned to discount. The production approach was calibrated to the institutional buyer audience's specific communication register — the visual quality and editorial clarity that communicates Access Bio's clinical credibility and product seriousness without the overwrought production style that distances healthcare marketing content from the real-world environments it is meant to serve.
Post-production editing delivered the polished, distribution-ready asset optimized for website deployment, sales enablement distribution, and the trade show, conference, and institutional sales contexts where Access Bio reaches the healthcare providers and procurement decision-makers whose adoption of the CareStart™ platform is the commercial and public health outcome the video was built to support.
Product explainer video delivered and deployed across Access Bio's website, sales enablement infrastructure, and distribution partner communications — giving the global health diagnostics company a permanent, professionally produced video asset that communicates CareStart™ product value to healthcare providers, institutional buyers, and distribution partners across the more than 100 countries where Access Bio's diagnostic platforms serve clinical and public health needs.
Every marketing team that struggles with video has the same problem — no system underneath the effort. VID installs yours in 30 days.
Not ready for the full system? Start with a single video →
VID helps marketing teams produce consistent, sales-aligned video. From one essential video asset to a fully installed video operating system. We build it, run it, or teach you how.
